Achieve Life Sciences Inc expected to post a loss of 32 cents a share - Earnings Preview

Achieve Life Sciences

07/03/2025 13:22

Achieve Life Sciences Inc ACHV.OQ ACHV.O is expected to show no change in quarterly revenue when it reports  results on March 11 for the period ending December 31 2024

​LSEG's mean analyst estimate for Achieve Life Sciences Inc is for a loss of 32 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Achieve Life Sciences Inc is $16.00​, above​ its last closing price of $3.14. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Sep. 30 2024
-0.28
-0.26
-0.36
Missed
-37.7
Jun. 30 2024
-0.23
-0.23
-0.25
Missed
-7.9
Mar. 31 2024
-0.25
-0.24
-0.26
Missed
-6.6​
Dec. 31 2023
-0.31
-0.31
-0.26
Beat
17.3
​​Sep. 30 2023
-0.37
-0.38
-0.34
Beat
10.2
Jun. 30 2023
-0.41
-0.42
-0.43
Missed
-2​
Mar. 31 2023
-0.68
-0.69
-0.50
Beat
27.1
Dec. 31 2022
-0.77
-0.83
-0.83
Met
0

This summary was machine generated March 7 at 13:22 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)